Teva Pharmaceutical Industries Limited (TEVJF)
 OTCMKTS  · Delayed Price · Currency is USD  
18.50
 0.00 (0.00%)
  At close: Oct 23, 2025
Teva Pharmaceutical Industries Employees
As of December 31, 2024, Teva Pharmaceutical Industries had 35,686 total employees, including 33,892 full-time and 1,794 part-time employees. The number of employees decreased by 786 or -2.16% compared to the previous year.
Employees 
 35,686
Change (1Y) 
 -786
Growth (1Y) 
 -2.16%
Revenue / Employee 
 $449,405
Profits / Employee 
 -$4,243
Market Cap 
22.98B
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 35,686 | -786 | -2.16% | 
| Dec 31, 2023 | 36,472 | 1,347 | 3.83% | 
| Dec 31, 2022 | 35,125 | -854 | -2.37% | 
| Dec 31, 2021 | 35,979 | -2,393 | -6.24% | 
| Dec 31, 2020 | 38,372 | -1,667 | -4.16% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Related Stocks
| Company Name | Employees | 
|---|---|
| American Oncology Network | 1,914 | 
| Jushi Holdings | 1,234 | 
| Glass House Brands | 374 | 
| Silence Therapeutics | 116 | 
| Elite Pharmaceuticals | 68 | 
| Northwest Biotherapeutics | 25 | 
| CytoDyn | 13 | 
| Nuo Therapeutics | 9 | 
Teva Pharmaceutical Industries News
- 10 days ago - Formycon, Teva Pharma Launch FYB201/Ranivisio Biosimilar In Pre-filled Syringe In Europe - Nasdaq
- 10 days ago - Teva (TEVA) Partners with Prestige Biopharma for Tuznue in Europe - GuruFocus
- 10 days ago - Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe - GlobeNewsWire
- 13 days ago - Teva Vs. Viatris: Who Will Dominate In President Trump's America? - Seeking Alpha
- 15 days ago - AFI Development - Vedomosti (Ведомости)
- 17 days ago - TEVA Gets FDA Nod for Uzedy Label Expansion in Bipolar I Disorder - Nasdaq
- 20 days ago - Teva : FDA Grants Expanded Approval For UZEDY To Treat Bipolar I Disorder In Adults - Nasdaq
- 20 days ago - FDA Expands Use of Teva's (TEVA) Uzedy for Bipolar I Disorder - GuruFocus